Human cytomegalovirus RNA vaccines
G Ciaramella, S John, K Mousavi - US Patent 10,064,935, 2018 - Google Patents
UVBYMVOUBXYSFV-XUTVFYLZSA-N 1-methylpseudouridine Chemical compound O=
C1NC (= O) N (C) C= C1 [C@ H] 1 [C@ H](O)[C@ H](O)[C@@ H](CO) O1 …
C1NC (= O) N (C) C= C1 [C@ H] 1 [C@ H](O)[C@ H](O)[C@@ H](CO) O1 …
Engineered nucleic acids and methods of use thereof
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
45893552&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
45893552&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
T Chakraborty, A De Fougerolles - US Patent 9,233,141, 2016 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
49235350&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
49235350&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Engineered nucleic acids and methods of use thereof
A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, eg
guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as …
guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as …
Modified polynucleotides encoding apoptosis inducing factor 1
T Chakraborty, A De Fougerolles - US Patent 9,301,993, 2016 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
49235350&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
49235350&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Engineering dendritic cells to enhance cancer immunotherapy
Cancer immunotherapy aims to establish immune-mediated control of tumor growth by
priming T-cell responses to target tumor-associated antigens. Three signals are required for …
priming T-cell responses to target tumor-associated antigens. Three signals are required for …
Modified polynucleotides encoding hepatitis A virus cellular receptor 2
S Bancel, T Chakraborty, A De Fougerolles… - US Patent …, 2017 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
49235350&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
49235350&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Telomerase as a universal tumor-associated antigen for cancer immunotherapy
RH Vonderheide - Oncogene, 2002 - nature.com
Although the search for pharmacologic inhibitors of telomerase activity represents a
promising approach for telomerase-based anti-cancer therapy, the immunological properties …
promising approach for telomerase-based anti-cancer therapy, the immunological properties …
Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines
Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …
Direct delivery of antigens to dendritic cells via antibodies specific for endocytic receptors as a promising strategy for future therapies
CHK Lehmann, L Heger, GF Heidkamp, A Baranska… - Vaccines, 2016 - mdpi.com
Dendritic cells (DCs) are the most potent professional antigen presenting cells and are
therefore indispensable for the control of immunity. The technique of antibody mediated …
therefore indispensable for the control of immunity. The technique of antibody mediated …